Severity
Moderate
FDA Drug recall · Reported October 22, 2014
Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium
Unit Dose Solutions Inc recalled Atorvastatin Calcium 40 MG Tablet, MFG: Apotex NDC# 6050525808 - a moderate-severity action.
Atorvastatin Calcium 40 MG Tablet, MFG: Apotex NDC# 6050525808 was recalled by Unit Dose Solutions Inc in October 22, 2014. Reason: Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose …. Check the official notice for the remedy. Verify recall #D-0017-2015 with the FDA Drug before acting.
The recall
Unit Dose Solutions Inc issued this moderate-severity FDA Drug recall-Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose ….
Sourced from official FDA Drug enforcement records. Verify recall #D-0017-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0017-2015) was formally reported on October 22, 2014, with the manufacturer initiating the action on June 2, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Unit Dose Solutions Inc is listed as the recalling firm, operating out of Morrisville, NC. Federal records list the affected scope as 1,177 packets.
The documented reason for this recall is: Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium Distribution data in the federal record shows the product reached: PA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1,177 packets
Related Recalls
6
5 from same agency
Atorvastatin Calcium 40 MG Tablet, MFG: Apotex NDC# 6050525808
Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0017-2015 |
| Date reported | October 22, 2014 |
| Date initiated | June 2, 2014 |
| Recalling firm | Unit Dose Solutions Inc |
| Firm location | Morrisville, NC |
| Affected scope | 1,177 packets |
| Distribution | PA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 22, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.